Annual report
7840.TEDINET S100TQR8
Period2023-04-01 → 2024-03-31
Filed2024-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 150
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥59.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥58.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥54.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥52.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥52.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥4.6bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥4.5bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥4.7bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.0bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.7bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.4bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.6bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.3bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥3.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥2.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥68.6bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥64.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥64.3bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥62.2bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥59.8bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥30.4bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥26.6bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥38.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥38.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥37.5bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥37.4bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥37.5bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.4bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥10.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥7.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.0bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥10.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥6.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.8bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.0bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥633m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥316m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥688m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥87.28 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.8 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥69.35 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.87 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.07 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥86.85 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,106.37 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,058.41 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,030.11 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥998.31 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥966.7 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 55.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.4% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.1% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.2% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.0% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,783 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 1,785 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 1,768 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 1,631 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,554 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥2.8bn | 2023-04-01 → 2024-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥2.8bn | 2022-04-01 → 2023-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥2.6bn | 2021-04-01 → 2022-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥2.2bn | 2020-04-01 → 2021-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥2.1bn | 2019-04-01 → 2020-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.2bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.2bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥1.2bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥979m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥63.0bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥59.2bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥58.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥61.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥58.0bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥28.9bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥23.1bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥34.0bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥36.1bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥36.7bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥37.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥38.6bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.8bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥33.27 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.16 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.05 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.33 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.17 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥33.1 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥39 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥36 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥33 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥984.75 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,003.13 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,007.52 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,002.94 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥995.28 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 54.0% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.0% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.3% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.6% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.5% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.4% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.9% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.1% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 38,397,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 41,397,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 41,397,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 41,397,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 41,397,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 56 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 58 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 55 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 16 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 18 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 81
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥16m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥555m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥548m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥783m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥285m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥285m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | −¥2.9bn |
| Reconciling Itemsreconciling | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥6m |
| Home Furnishing And Healthreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥280m |
| Home Furnishing And Healthreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥557m |
| Home Furnishing And Healthreportable segment | employees | at 2024-03-31 | 506 pure |
| Home Furnishing And Healthreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥20.0bn |
| Home Furnishing And Healthreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥19.7bn |
| Home Furnishing And Healthreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥270m |
| Home Furnishing And Healthreportable segment | segment assets | at 2024-03-31 | ¥25.5bn |
| Home Furnishing And Healthreportable segment | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Medical Servicesreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥4.6bn |
| Medical Servicesreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥4.8bn |
| Medical Servicesreportable segment | employees | at 2024-03-31 | 1221 pure |
| Medical Servicesreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥38.9bn |
| Medical Servicesreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥38.9bn |
| Medical Servicesreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥6m |
| Medical Servicesreportable segment | segment assets | at 2024-03-31 | ¥45.2bn |
| Medical Servicesreportable segment | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥3.5bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥4.9bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥5.3bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥58.9bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥58.6bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥277m |
| —segment total | segment assets | at 2024-03-31 | ¥70.7bn |
| —segment total | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥4.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥59.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥59.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥285m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥71.5bn |
| Total Of Reportable Segments And Otherssegment total | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥4.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥17m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥583m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥575m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥797m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥2m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥68m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥12m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥242m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥242m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | −¥5.3bn |
| Reconciling Itemsreconciling | segment ordinary income | 2022-04-01 → 2023-03-31 | −¥23m |
| Home Furnishing And Healthreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥568m |
| Home Furnishing And Healthreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥596m |
| Home Furnishing And Healthreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥20.2bn |
| Home Furnishing And Healthreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥19.9bn |
| Home Furnishing And Healthreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥231m |
| Home Furnishing And Healthreportable segment | segment assets | at 2023-03-31 | ¥25.6bn |
| Home Furnishing And Healthreportable segment | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Medical Servicesreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥4.3bn |
| Medical Servicesreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥4.9bn |
| Medical Servicesreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥38.1bn |
| Medical Servicesreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥38.1bn |
| Medical Servicesreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥3m |
| Medical Servicesreportable segment | segment assets | at 2023-03-31 | ¥43.6bn |
| Medical Servicesreportable segment | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥3.4bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥4.8bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥5.5bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥58.2bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥58.0bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥234m |
| —segment total | segment assets | at 2023-03-31 | ¥69.2bn |
| —segment total | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥58.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥58.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥242m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥70.0bn |
| Total Of Reportable Segments And Otherssegment total | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥4.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,682
| Item | Context | Value | Unit |
|---|---|---|---|
| All employees ratio of male employees taking childcare leave metrics of consolidated subsidiaries | CurrentYearInstant_Row3Member | － | |
| All employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row3Member | 0.651 | |
| Regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row3Member | 0.718 | |
| Non regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row3Member | 0.715 | |
| Ratio of female employees in managerial positions metrics of consolidated subsidiaries | CurrentYearInstant_Row4Member | 0.167 | |
| All employees ratio of male employees taking childcare leave metrics of consolidated subsidiaries | CurrentYearInstant_Row4Member | － | |
| All employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row4Member | 0.799 | |
| Regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row4Member | 0.769 | |
| Non regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row4Member | 0.821 | |
| Ratio of female employees in managerial positions metrics of consolidated subsidiaries | CurrentYearInstant_Row5Member | － | |
| All employees ratio of male employees taking childcare leave metrics of consolidated subsidiaries | CurrentYearInstant_Row5Member | 1.000 | |
| All employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row5Member | 0.643 | |
| Regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row5Member | 0.669 | |
| Non regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row5Member | 1.131 | |
| Ratio of female employees in managerial positions metrics of consolidated subsidiaries | CurrentYearInstant_Row6Member | － | |
| All employees ratio of male employees taking childcare leave metrics of consolidated subsidiaries | CurrentYearInstant_Row6Member | － | |
| All employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row6Member | 0.920 | |
| Regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row6Member | 0.881 | |
| Non regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row6Member | － | |
| Ratio of female employees in managerial positions metrics of consolidated subsidiaries | CurrentYearInstant_Row7Member | 0.071 | |
| All employees ratio of male employees taking childcare leave metrics of consolidated subsidiaries | CurrentYearInstant_Row7Member | 0.250 | |
| All employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row7Member | 0.682 | |
| Regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row7Member | 0.724 | |
| Non regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row7Member | 0.765 | |
| Gross scope1 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior3YearDuration_ConsolidatedAccountingGroupMember | 5444 | |
| Gross scope1 greenhouse gas emissions scope1 and2 greenhouse gas emissions | CurrentYearDuration_ConsolidatedAccountingGroupMember | 4933 | |
| Gross scope2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | Prior3YearDuration_ConsolidatedAccountingGroupMember | 3937 | |
| Gross scope2 greenhouse gas emissions scope1 and2 greenhouse gas emissions | CurrentYearDuration_ConsolidatedAccountingGroupMember | 2588 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 34.3 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 35 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 4.8 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 15 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 2.6 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 3.0 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row4Member | 100.0 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row4Member | 100 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row5Member | 21.6 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row5Member | 50 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row6Member | 68.1 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row6Member | 72.0 | |
| Research and development expenses research and development activities | CurrentYearDuration | 178000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02472-000MedicalServicesReportableSegmentsMember | 115000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02472-000HomeFurnishingAndHealthReportableSegmentsMember | 63000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 4905000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02472-000MedicalServicesReportableSegmentsMember | 4624000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02472-000HomeFurnishingAndHealthReportableSegmentsMember | 280000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 38397500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 38397500 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 38397500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 38397500 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |